Maria Azkona
Pamplona, NC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Ultra-low-pass whole-genome sequencing of bile cfDNA in patients with biliary strictures.
Journal: eGastroenterology
Published: March 25, 2026
Demonstration of SLU7 as a new cancer target.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 19, 2025
Caspases compromise SLU7 and UPF1 stability and NMD activity during hepatocarcinogenesis.
Journal: JHEP reports : innovation in hepatology
Published: December 04, 2023
Splicing Factor SLU7 Prevents Oxidative Stress-Mediated Hepatocyte Nuclear Factor 4α Degradation, Preserving Hepatic Differentiation and Protecting From Liver Damage.
Journal: Hepatology (Baltimore, Md.)
Published: April 14, 2021
The splicing regulator SLU7 is required to preserve DNMT1 protein stability and DNA methylation.
Journal: Nucleic acids research
Published: March 22, 2021
Splicing events in the control of genome integrity: role of SLU7 and truncated SRSF3 proteins.
Journal: Nucleic acids research
Published: July 26, 2018
Splicing regulator SLU7 preserves survival of hepatocellular carcinoma cells and other solid tumors via oncogenic miR-17-92 cluster expression.
Journal: Oncogene
Published: June 08, 2015
Splicing regulator SLU7 is essential for maintaining liver homeostasis.
Journal: The Journal of clinical investigation
Published: November 20, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026